H. Lundbeck A/S

General ticker "HLUBF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $5.4B (TTM average)

H. Lundbeck A/S follows the US Stock Market performance with the rate: 17.0%.

Estimated limits based on current volatility of 1.8%: low 6.47$, high 6.67$

Factors to consider:

  • Company pays dividends (irregularly): last record date 2026-03-20, amount 0.18$ (Y2.81%)
  • Price in estimated range
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [4.62$, 7.21$]
  • 2026-12-31 to 2027-12-31 estimated range: [4.89$, 7.64$]

Financial Metrics affecting the HLUBF estimates:

  • Positive: with PPE of 10.8 at the end of fiscal year the price was neutral
  • Positive: 11.37 < Operating cash flow per share per price, % of 14.49
  • Positive: 22.58 < Operating profit margin, % of 26.05
  • Positive: Industry inventory ratio change (median), % of -0.31 <= 0
  • Positive: Inventory ratio change, % of 0.19 <= 0.41
  • Positive: 5.14 < Return on assets ratio (scaled to [-100,100]) of 5.58
  • Positive: -2.60 < Investing cash flow per share per price, % of -1.81
  • Negative: 42.26 < Shareholder equity ratio, % of 46.11 <= 49.86
  • Positive: Interest expense per share per price, % of 1.60 <= 2.54

Similar symbols

Short-term HLUBF quotes

Long-term HLUBF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue DKK19,912.00MM DKK22,004.00MM DKK24,295.84MM
Operating Expenses DKK16,717.00MM DKK18,734.00MM DKK17,967.21MM
Operating Income DKK3,195.00MM DKK3,270.00MM DKK6,328.63MM
Non-Operating Income DKK-202.00MM DKK449.00MM DKK-1,851.80MM
Interest Expense DKK54.00MM DKK113.00MM DKK539.77MM
R&D Expense DKK3,457.00MM DKK4,501.00MM DKK4,687.36MM
Income(Loss) DKK2,993.00MM DKK3,719.00MM DKK4,476.84MM
Taxes DKK703.00MM DKK576.00MM DKK1,292.07MM
Net Income(Loss)* DKK1,385.00MM DKK3,016.00MM DKK3,184.77MM
Stockholders Equity DKK22,045.00MM DKK25,010.00MM DKK24,846.59MM
Inventory DKK4,427.00MM DKK3,983.00MM DKK4,462.87MM
Assets DKK37,407.00MM DKK56,976.00MM DKK53,889.66MM
Operating Cash Flow DKK4,080.00MM DKK3,326.00MM DKK4,886.91MM
Capital expenditure DKK501.00MM DKK565.00MM DKK552.75MM
Investing Cash Flow DKK-498.00MM DKK-15,286.00MM DKK-609.62MM
Financing Cash Flow DKK-2,085.00MM DKK11,629.00MM DKK-5,466.59MM
Earnings Per Share** DKK1.40 DKK3.04 DKK3.21

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.